Skip to main content

This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content may only be relevant to HCPs practising in Great Britain (England, Scotland and Wales) according to product availability. This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

  1. Article
  2. Source: Campus Sanofi
  3. 16 Feb 2026
5 min

SARCLISA® (isatuximab) in Clinical Practice Case Studies and Translating IMROZ into Clinic

Author:

Prescribing Information for SARCLISA® (isatuximab) can be found via the Product Card at the bottom of the page.

Dr Ceri Bygrave Consultant Haematologist, University Hospital of Wales, Cardiff


Dr Ceri Bygrave talks through how to translate IMROZ into clinic.

Professor Karthik Ramasamy Consultant Haematologist, Oxford University Hospitals NHS Trust, Oxford

Professor Karthik Ramasamy presents an 81-year-old frail patient with Ti NDMM.

Professor Karthik Ramasamy Consultant Haematologist, Oxford University Hospitals NHS Trust, Oxford

Professor Karthik Ramasamy presents a 70- year-old retired triathlete with Ti NDMM.

Dr Sally Moore Consultant Haematologist, Royal United Hospital, Bath and University Hospital, Bristol

Dr Sally Moore talks through treatment options for a 73-year-old female patient with Ti NDMM.

Get in touch with the Oncology Team

Sarclisa logo

Ti NDMM

Learn more  →

Prescribing information UK

MAT-XU-2202578 (v7.0)
Date of preparation: August 2025

MAT-XU-2600377 (v1.0) Date of Preparation: February 2026  

Related Content

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to the Sanofi drug safety department on Tel: +44 (0) 800 0902 314. Alternatively, send via email to UK-drugsafety@sanofi.com
Back to top
Privacy Notice Update | We have updated our Privacy Notice for Healthcare Professionals to improve your experience collaborating with us, maintain high standards of privacy and ultimately strengthen the trust you place in us. Key improvements include enhanced clarity on why and how Sanofi processes your personal data.
Staying in TouchTerms of UseCookie PolicySitemapAccessibility Statement

© Sanofi 2026. All rights reserved.

MAT-XU-2300297 (v8.0) - Date of Preparation: December 2025

Privacy Notice Update | We have updated our Privacy Notice for Healthcare Professionals to improve your experience collaborating with us, maintain high standards of privacy and ultimately strengthen the trust you place in us. Key improvements include enhanced clarity on why and how Sanofi processes your personal data.
Staying in TouchTerms of UseCookie PolicySitemapAccessibility Statement
Back to top

© Sanofi 2026. All rights reserved.

MAT-XU-2300297 (v8.0) - Date of Preparation: December 2025